CRISPR 2.0: a new wave of gene editors heads for clinical trials.
Nature, 624(7991): 234-235 PMID 38062143 DOI 10.1038/d41586-023-03797-7
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.